Hematologic diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients with histologically-confirmed hematologic disease 2)Patients who received informed consent 3)>=60 years old 4)Written informed consent form prior to participation in the study
Exclusion criteria
Exclusion criteria: 1)Ptients with consciousness disturbance 2)Patients with severe physical dysfunction 3)Patients with severe mental disorder 4)Patients with pacemaker
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The relationship between simplified GA and prognosis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival(OS) Progression free survival(PFS) Early mortality Response rate Adverse event Treatment | — |
Countries
Japan
Contacts
Yokohama Municipal Citizen's Hospital Department of Hematology